Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward Rapid, Widely Available Autologous CAR-T Cell Therapy - Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital.
Hort S, Herbst L, Bäckel N, Erkens F, Niessing B, Frye M, König N, Papantoniou I, Hudecek M, Jacobs JJL, Schmitt RH. Hort S, et al. Among authors: hudecek m. Front Med (Lausanne). 2022 Jun 6;9:913287. doi: 10.3389/fmed.2022.913287. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35733863 Free PMC article.
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.
Munawar U, Zhou X, Prommersberger S, Nerreter S, Vogt C, Steinhardt MJ, Truger M, Mersi J, Teufel E, Han S, Haertle L, Banholzer N, Eiring P, Danhof S, Navarro-Aguadero MA, Fernandez-Martin A, Ortiz-Ruiz A, Barrio S, Gallardo M, Valeri A, Castellano E, Raab P, Rudert M, Haferlach C, Sauer M, Hudecek M, Martinez-Lopez J, Waldschmidt J, Einsele H, Rasche L, Kortüm KM. Munawar U, et al. Among authors: hudecek m. Commun Biol. 2023 Dec 21;6(1):1299. doi: 10.1038/s42003-023-05683-4. Commun Biol. 2023. PMID: 38129580 Free PMC article.
New targets and technologies for CAR-T cells.
Freitag F, Maucher M, Riester Z, Hudecek M. Freitag F, et al. Among authors: hudecek m. Curr Opin Oncol. 2020 Sep;32(5):510-517. doi: 10.1097/CCO.0000000000000653. Curr Opin Oncol. 2020. PMID: 32657796 Review.
T-Cell Metabolism in Graft Versus Host Disease.
Karl F, Hudecek M, Berberich-Siebelt F, Mackensen A, Mougiakakos D. Karl F, et al. Among authors: hudecek m. Front Immunol. 2021 Oct 29;12:760008. doi: 10.3389/fimmu.2021.760008. eCollection 2021. Front Immunol. 2021. PMID: 34777373 Free PMC article. Review.
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations.
Ammar D, Schapitz I, Luu M, Hudecek M, Meyer M, Taps T, Schröder B, Ivics Z, Sanges C, Franz P, Koehl U, Negre H, Johanna I, Awigena-Cook J. Ammar D, et al. Among authors: hudecek m. Front Immunol. 2023 Nov 24;14:1280826. doi: 10.3389/fimmu.2023.1280826. eCollection 2023. Front Immunol. 2023. PMID: 38077331 Free PMC article. Review.
116 results